Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Itai Benhar

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Expert Opinion on Biological Therapy|May 5, 2007
Design of synthetic antibody librariesItai Benhar
Mabs|January 13, 2010
"Inclonals": IgGs and IgG-enzyme fusion proteins produced in an E. coli expression-refolding systemRahely Hakim, Itai Benhar
Infectious Disorders Drug Targets|September 28, 2007
Targeted anti bacterial therapyIftach Yacoby, Itai Benhar
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2009
Design of a human synthetic combinatorial library of single-chain antibodiesLimor Nahary, Itai Benhar
Current Protocols in Immunology|April 25, 2008
Phage display of single-chain antibody constructsItai Benhar, Yoram Reiter
Nanomedicine (London, England)|May 31, 2008
Antibacterial nanomedicineIftach Yacoby, Itai Benhar
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 2, 2017
Novel immune check point inhibiting antibodies in cancer therapy-Opportunities and challengesYael Diesendruck, Itai Benhar
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2002
Large scale production of recombinant antibodies by utilizing cellulose-binding domainsItai Benhar, Yevgeny Berdichevsky
Journal of Nanobiotechnology|December 22, 2011
In vivo characteristics of targeted drug-carrying filamentous bacteriophage nanomedicinesLilach Vaks, Itai Benhar
Methods in Molecular Biology (Clifton, N.J.)|March 23, 2011
Antibacterial application of engineered bacteriophage nanomedicines: antibody-targeted, chloramphenicol prodrug loaded bacteriophages for inhibiting the growth of Staphylococcus aureus bacteriaLilach Vaks, Itai Benhar
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Expert Opinion on Biological Therapy|May 5, 2007
Design of synthetic antibody librariesItai Benhar
Mabs|January 13, 2010
"Inclonals": IgGs and IgG-enzyme fusion proteins produced in an E. coli expression-refolding systemRahely Hakim, Itai Benhar
Infectious Disorders Drug Targets|September 28, 2007
Targeted anti bacterial therapyIftach Yacoby, Itai Benhar
Methods in Molecular Biology (Clifton, N.J.)|March 3, 2009
Design of a human synthetic combinatorial library of single-chain antibodiesLimor Nahary, Itai Benhar
Current Protocols in Immunology|April 25, 2008
Phage display of single-chain antibody constructsItai Benhar, Yoram Reiter
Nanomedicine (London, England)|May 31, 2008
Antibacterial nanomedicineIftach Yacoby, Itai Benhar
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 2, 2017
Novel immune check point inhibiting antibodies in cancer therapy-Opportunities and challengesYael Diesendruck, Itai Benhar
Methods in Molecular Biology (Clifton, N.J.)|November 5, 2002
Large scale production of recombinant antibodies by utilizing cellulose-binding domainsItai Benhar, Yevgeny Berdichevsky
Journal of Nanobiotechnology|December 22, 2011
In vivo characteristics of targeted drug-carrying filamentous bacteriophage nanomedicinesLilach Vaks, Itai Benhar
Methods in Molecular Biology (Clifton, N.J.)|March 23, 2011
Antibacterial application of engineered bacteriophage nanomedicines: antibody-targeted, chloramphenicol prodrug loaded bacteriophages for inhibiting the growth of Staphylococcus aureus bacteriaLilach Vaks, Itai Benhar
Pageof 10